Health Care & Life Sciences » Pharmaceuticals | Adamis Pharmaceuticals Corp.

Adamis Pharmaceuticals Corp. | Ownership

Companies that own Adamis Pharmaceuticals Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
1,282,352
2.71%
7,800
0%
06/30/2018
Deka Investment GmbH
700,000
1.48%
700,000
0%
06/30/2018
BlackRock Fund Advisors
287,460
0.61%
19,574
0%
06/30/2018
Geode Capital Management LLC
187,055
0.4%
12,498
0%
06/30/2018
Leisure Capital Management, Inc.
157,301
0.33%
13,376
0.36%
06/30/2018
Bard Associates, Inc.
151,800
0.32%
-1,150
0.19%
06/30/2018
Northern Trust Investments, Inc.
136,020
0.28%
-3,516
0%
06/30/2018
BMO Asset Management, Inc.
113,800
0.24%
113,800
0%
06/30/2018
Walleye Trading Advisors LLC
87,098
0.18%
0
0.01%
06/30/2018
Susquehanna Financial Group LLLP
76,897
0.16%
-18,751
0%
06/30/2018

About Adamis Pharmaceuticals

View Profile
Address
11682 El Camino Real
San Diego California 92130
United States
Employees -
Website http://www.adamispharmaceuticals.com
Updated 07/08/2019
Adamis Pharmaceuticals Corp. is a biopharmaceutical company which is focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy. . Its activities include the combination of pharmaceuticals and biotechnology to produce medicines for patients, and physicians.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.